Vitelle Irospan and Alcohol/Food Interactions
There are 2 alcohol/food/lifestyle interactions with Vitelle Irospan (ascorbic acid/ferrous sulfate).
Ferrous Sulfate Food
Moderate Food Interaction
ADJUST DOSING INTERVAL: Concomitant use of some oral medications may reduce the bioavailability of orally administered iron, and vice versa.
Food taken in conjunction with oral iron supplements may reduce the bioavailability of the iron. However, in many patients intolerable gastrointestinal side effects occur necessitating administration with food.
MANAGEMENT: Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect. Some studies suggest administration of iron with ascorbic acid may enhance bioavailability. In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased. Consult the product labeling for specific separation times and monitor clinical responses as appropriate.
References (2)
- "Product Information. Feosol (ferrous sulfate)." SmithKline Beecham
- (2021) "Product Information. Accrufer (ferric maltol)." Shield Therapeutics
Switch to consumer interaction data
Ascorbic Acid High Blood Pressure (Hypertension)
Moderate Potential Hazard, Moderate plausibility
ascorbic acid (vitamin C) - sodium
Ascorbic acid preparations contain sodium. The sodium content should be considered when used in patients with sodium restricted diets and conditions require sodium restriction, such as congestive heart failure, hypertension, and fluid retention.
References (1)
- "Product Information. Cemill 500 (ascorbic acid)." Abbott Pharmaceutical
Switch to consumer interaction data
Vitelle Irospan drug interactions
There are 116 drug interactions with Vitelle Irospan (ascorbic acid/ferrous sulfate).
Vitelle Irospan disease interactions
There are 7 disease interactions with Vitelle Irospan (ascorbic acid/ferrous sulfate) which include:
- hemoglobin abnormalities
- hemolysis
- kidney stones
- sodium
- achlorhydria
- gastrointestinal irritation
- dialysis
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.